- Home
- SMTI vs SERA Comparison
SMTI vs SERA Comparison
Compare SMTI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMTI | SERA |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 130.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SMTI | SERA |
|---|---|---|
| Price | $23.21 | $2.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | 44.5K | ★ 62.9K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,877,532.00 | $95,000.00 |
| Revenue This Year | $21.60 | $25.84 |
| Revenue Next Year | $16.70 | $347.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | 1.06 |
| 52 Week Low | $18.90 | $1.37 |
| 52 Week High | $38.68 | $8.73 |
Technical Indicators
Market Signals| Indicator | SMTI | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 45.32 | 36.15 |
| Support Level | $23.76 | $3.38 |
| Resistance Level | $25.41 | $3.67 |
| Average True Range (ATR) | 1.05 | 0.27 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 0.00 | 8.70 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.